Patent application number | Description | Published |
20120258171 | COMPOSITION COMPRISING FESOTERODINE AND FIBER - The invention relates to a pharmaceutical composition containing (a) fesoterodine and/or fesoterodine metabolites and (b) fibers, wherein the weight ratio of components (a):(b) is in the range from 1:50 to 1:2; and oral dosage forms containing the pharmaceutical composition. The invention further relates to dry methods of preparing those dosage forms. | 10-11-2012 |
20120308652 | ORAL FORM OF ADMINISTRATION COMPRISING ENTECAVIR - The invention relates to pharmaceutical formulations, preferably in the form of an oral dosage form, for the treatment of chronic hepatitis-B virus infections, containing micronised Entecavir, and processes for preparing it. The invention further relates to intermediates containing micronised entecavir, in which the D50 value for the particle size distribution is less than 50 μm, and processes for preparing them. | 12-06-2012 |
20130116333 | SOLID TAPENTADOL IN NON-CRYSTALLINE FORM - The invention relates to solid tapentadol in non-crystalline form together with a surface stabiliser in the form of a stable intermediate. In the intermediate of the invention, tapentadol is preferably present in amorphous form or in the form of a solid solution. The invention further relates to methods of producing tapentadol in a solid, non-crystalline form and to pharmaceutical formulations containing solid, non-crystalline tapentadol. | 05-09-2013 |
20140094478 | COMPOSITION AND TABLET COMPRISING RALTEGRAVIR - The present invention relates to a composition and tablet comprising raltegravir and to a process for the preparation of such tablet. | 04-03-2014 |
Patent application number | Description | Published |
20080275063 | Inhibitors of protein kinases - The present invention provides new compounds. The compounds are useful as CDK5 inhibitors, and accordingly they can be included in pharmaceutical compositions for treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases. | 11-06-2008 |
20100168144 | INHIBITORS OF PROTEIN KINASES - The present invention relates to inhibitors of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to methods of preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases comprising the administration of an effective amount of at least one inhibitor of cyclin-dependent kinases. formula (I). | 07-01-2010 |
20100184780 | INHIBITORS OF PROTEIN KINASES - The present invention provides new compounds. The compounds are useful as CDK5 inhibitors, and accordingly they can be included in pharmaceuticals compositions for treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases. formula (I). | 07-22-2010 |
20100184789 | INHIBITORS OF PROTEIN KINASES - The present invention relates to inhibitors of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to methods of preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases comprising the administration of an effective amount of at least one inhibitor of cyclin-dependent kinases. | 07-22-2010 |
20110306602 | 4, 6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES - The present invention relates to inhibitors of general Formula (I) of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to compounds for preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases. | 12-15-2011 |
20130331407 | INHIBITORS OF PROTEIN KINASES - The present invention relates to inhibitors of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to methods of preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases comprising the administration of an effective amount of at least one inhibitor of cyclin-dependent kinases. | 12-12-2013 |
20130338147 | 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES - The present invention relates to inhibitors of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to methods of preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases comprising the administration of an effective amount of at least one inhibitor of cyclin-dependent kinases. | 12-19-2013 |
Patent application number | Description | Published |
20110207681 | USE OF GLUCOSYLGLYCEROL - The invention relates to the use of glucosylglycerol or glucosylglycerol esters with a view to increasing the expression of cell protective enzymes for the protection and stabilization of human skin and/or mucous membranes. It has been demonstrated that glucosylglycerol plays an effective role in the stimulation and activation of cell protective enzymes such as superoxide dismutase. It is thus possible in this manner to protect human skin cells effectively against damaging external influences. | 08-25-2011 |
20140243512 | SORBENT COMPRISING AN AROMATIC RING SYSTEM ON ITS SURFACE FOR THE PURIFICATION OF ORGANIC MOLECULES - In a first embodiment the present invention relates to a sorbent comprising a porous inorganic solid support material having on its surface a film of a crosslinked polyvinylamine comprising derivatized amine groups and amine groups binding to the surface of the support material via electron donor/acceptor interactions. In a second embodiment the present invention relates to a sorbent comprising a solid support material, the surface of which comprises a residue of a general formula (I), wherein the residue is attached via a covalent single bond to a functional group on the surface of either the bulk solid support material itself or of a polymer film on the surface of the solid support material. Furthermore, the present invention relates to the use of the sorbents according to the invention for the purification of organic molecules, in particular pharmaceutical active compounds, preferably in chromatographic applications. | 08-28-2014 |
20140336355 | ION-EXCHANGER MATERIAL WITH HIGH SALT-TOLERANCE - The present invention relates to a crosslinked sulphonated polymer or a crosslinked sulphonated polymer coated with a crosslinked polymer containing amino groups for use as an ion exchanger material of high salt tolerance for separating off macromolecules from a solution which originates from a biological source. | 11-13-2014 |
20140343261 | SORBENT COMPRISING ON ITS SURFACE AN ALIPHATIC UNIT HAVING AN ANIONIC OR DEPROTONIZABLE GROUP FOR THE PURIFICATION OF ORGANIC MOLECULES - The present invention relates to a sorbent comprising a solid support material, the surface of which comprises a residue of a general formula (I), wherein the residue is attached via a covalent single bond to a functional group on the surface of either the bulk solid support material itself or of a polymer film on the surface of the solid support material. Furthermore, the present invention relates to the use of the sorbent according to the invention for the purification of organic molecules, in particular pharmaceutically active compounds, preferably in chromatographic application. | 11-20-2014 |
20150045533 | SORBENT COMPRISING ON ITS SURFACE AN ALIPHATIC UNIT FOR THE PURIFICATION OF ORGANIC MOLECULES - The present invention relates to a sorbent comprising a solid support material, the surface of which comprises a residue of a general formula (I), wherein the residue is attached via a covalent single bond to a functional group on the surface of either the bulk solid support material itself or of a polymer film on the surface of the solid support material. Furthermore, the present invention relates to the use of the sorbent according to the invention for the purification of organic molecules, in particular pharmaceutically active compounds, preferably in chromatographic applications | 02-12-2015 |
20150045545 | SORBENT COMPRISING ON ITS SURFACE AN AROMATIC RING SYSTEM HAVING AN ANIONIC OR DEPROTONIZABLE GROUP FOR THE PURIFICATION OF ORGANIC MOLECULES - The present invention relates to a sorbent comprising a solid support material, the surface of which comprises a residue of a general formula (I), wherein the residue is attached via a covalent single bond to a functional group on the surface of either the bulk solid support material itself or of a polymer film on the surface of the solid support material. Furthermore, the present invention relates to the use of the sorbent according to the invention for the purification of organic molecules, in particular pharmaceutically active compounds, preferably in chromatographic applications. | 02-12-2015 |
Patent application number | Description | Published |
20130275997 | Method and System For Exception-Less System Calls In An Operating System - A method and system is disclosed which can enhance the performance of computer systems by altering the operation of the operating system of those computer systems. The invention provides a system and method for making exception-less system calls, decoupling the invocation and execution of system calls, thus avoiding or reducing the direct and indirect overheads associated with making a conventional exception-based system call. The invention can be employed with single core processor systems and with multi-core processor systems, both affording improved temporal execution locality and the later also providing improved spatial execution locality. The system and method can be employed in a wide range of operating systems. | 10-17-2013 |
20130290644 | Method and System Method and System For Exception-Less System Calls For Event Driven Programs - A method and system is disclosed which can enhance the performance of computer systems by altering the operation of the operating system of those computer systems. The invention provides a system and method for making exception-less system calls, thus avoiding or reducing the direct and indirect overheads associated with making an exception-based system call. The invention can be employed with single core processor systems and with multi-core processor systems, both affording improved temporal execution locality and the later also providing improved spatial execution locality. The system and method can be employed in a wide range of operating systems. | 10-31-2013 |
20140223447 | Method and System For Exception-Less System Calls In An Operating System - A method and system is disclosed which can enhance the performance of computer systems by altering the operation of the operating system of those computer systems. The invention provides a system and method for making exception-less system calls, decoupling the invocation and execution of system calls, thus avoiding or reducing the direct and indirect overheads associated with making a conventional exception-based system call. The invention can be employed with single core processor systems and with multi-core processor systems, both affording improved temporal execution locality and the later also providing improved spatial execution locality. The system and method can be employed in a wide range of operating systems. | 08-07-2014 |